Research Development - Mayne Pharma Group Ltd (ASX:MYX) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 7.12 AUD -0.28%

Updated:

Mayne Pharma Group Ltd
Research & Development

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Mayne Pharma Group Ltd
Research & Development Peer Comparison

RCE

NEU

BOT

PBP

C

CU6

Company		Research & Development	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Mayne Pharma Group Ltd ASX:MYX	Research & Development -AU$15.7m	CAGR 3-Years 10%	CAGR 5-Years -5%	CAGR 10-Years N/A
	Recce Pharmaceuticals Ltd ASX:RCE	Research & Development N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Neuren Pharmaceuticals Ltd ASX:NEU	Research & Development -AU$26.8m	CAGR 3-Years -51%	CAGR 5-Years -34%	CAGR 10-Years -12%
	Botanix Pharmaceuticals Ltd ASX:BOT	Research & Development -AU$6.7m	CAGR 3-Years 11%	CAGR 5-Years 15%	CAGR 10-Years -22%
	Probiotec Ltd ASX:PBP	Research & Development N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
C	Clarity Pharmaceuticals Ltd ASX:CU6	Research & Development -AU$31.5m	CAGR 3-Years -65%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Research & Development amounts to -15.7m AUD.

Over the last year, the Research & Development growth was -29%. The average annual Research & Development growth rates for Mayne Pharma Group Ltd have been 10% over the past three years , -5% over the past five years .

Join more than 136,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.